Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of sumatriptan in combination with lithium for treatment of cluster headache (Phase II pilot)
2010-019058-42Phase 2Terminated
- Sponsor
- Azienda Ospedaliero Universitaria di Cagliari
- Start
- Mar 2010
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of sumatriptan and lithium in Cluster Headache (CH), sponsored by Azienda Ospedaliero Universitaria di Cagliari. Primary endpoint: Incidence of serotonin syndrome. Started Mar 2010; status: terminated.
02
Drugs
sumatriptanlithium
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on 2010-019058-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019058-42.